Created in 2019 (Belgium), Handl Therapeutics has more than 357 sister brands and more than 22 660 competing brands. The Handl Therapeutics brand is owned by UCB , a company listed in Brussels. Its International Securities Identification Number (ISIN) is BE0003739530. Handl Therapeutics belongs to the Healthcare business sector.
Logo Handl Therapeutics

Handl Therapeutics is a brand owned by UCB (UCB)

| Cotée à Brussels
BE | Date created : 2019 | Activity area : Healthcare
Share price 24-11-2020

91.06 EUR

Yield
(Dividend per share)

1.35% (annualized)

Share price variations over 1 year

+25.70%

(2015-2019)
Stoxx Europe 600 : +21,39%
S&P 500 NY : +54,84%
Share price variations over 5 years

+11.33%

Investment simulator :
arrow cursor
Amount invested
91.06 EUR
Portfolio valuation
UCB ( Handl Therapeutics ) over 5 years* :

Rival brands
Handl Therapeutics

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances